期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Pulsatile gonadotropin-releasing hormone therapy induces spermatogenesis in pituitary stalk interruption syndrome:A case report and review of the literature
1
作者 Jin-Long Xie Hai-Ying Zhu +5 位作者 Yang Dong Ping-Ping Sun dan-dan qi Su-Xian Luan Yan Zhang Hua-Gang Ma 《World Journal of Clinical Cases》 SCIE 2024年第20期4348-4356,共9页
BACKGROUND Pituitary stalk interruption syndrome(PSIS)is a rare anatomical defect of the pituitary gland falling under the spectrum of holoprosencephaly phenotypes.It is characterized by a deficiency in anterior pitui... BACKGROUND Pituitary stalk interruption syndrome(PSIS)is a rare anatomical defect of the pituitary gland falling under the spectrum of holoprosencephaly phenotypes.It is characterized by a deficiency in anterior pituitary hormones,such as growth hormone,gonadotropins,and thyroid hormones.Due to the syndrome's rarity and nonspecific manifestations,there is a lack of standardized treatment strategies.Consequently,early diagnosis through imaging and on-time intervention are crucial for improving patients’outcomes.CASE SUMMARY A 30-year-old man presented with absent secondary sexual characteristics and azoospermia.Laboratory evaluation revealed a deficiency in gonadotropins,while thyroid function was mostly within normal ranges.Magnetic resonance imaging of the pituitary gland showed pituitary stalk agenesis,hypoplasia of the anterior pituitary,and ectopic posterior pituitary,leading to the diagnosis of PSIS.Initially,the patient underwent 6 mo of gonadotropin therapy without significant changes in hormone levels and secondary sexual characteristics.Pulsatile gonadotropin-releasing hormone therapy was then administered,resulting in the detection of sperm in the semen analysis within 3 mo.After 6 mo,routine semen tests showed normal semen quality.The couple faced challenges in conceiving due to abstinence and underwent three cycles of artificial insemination,which was unsuccessful.They also attempted in vitro fertilization,but unfortunately,the woman experienced a miscarriage 10 wk after the embryo transfer.CONCLUSION Early detection,accurate diagnosis,and timely treatment are crucial in improving the quality of life and fertility of PSIS patients. 展开更多
关键词 Pituitary stalk interruption syndrome Hypogonadotropic hypogonadism SPERMATOGENESIS Pulsatile gonadotropinreleasing hormone therapy Case report
下载PDF
丹参多酚酸对老年脑卒中患者血清半乳糖凝集素-3、超敏C反应蛋白水平的影响 被引量:6
2
作者 王欢 魏书艳 +3 位作者 杨凡 齐丹丹 李轩 王佩 《中国现代医学杂志》 CAS 2019年第17期75-78,共4页
目的观察注射用丹参多酚酸对大动脉粥样硬化型脑卒中患者半乳糖凝集素-3、超敏C 反应蛋白(hs-CRP)水平的影响及近期临床疗效。方法根据TOAST 病因分型选取2017 年1 ~ 12 月于保定市第一中心医院就诊的大动脉粥样硬化型脑卒中患者202 例... 目的观察注射用丹参多酚酸对大动脉粥样硬化型脑卒中患者半乳糖凝集素-3、超敏C 反应蛋白(hs-CRP)水平的影响及近期临床疗效。方法根据TOAST 病因分型选取2017 年1 ~ 12 月于保定市第一中心医院就诊的大动脉粥样硬化型脑卒中患者202 例。随机分为两组,对照组以注射用血栓通及常规治疗方式治疗;实验组以注射用丹参多酚酸及常规治疗方式治疗;同期健康对照者200 例(健康组)。检测大动脉粥样硬化型脑卒中患者入院时及健康对照者清半乳糖凝集素-3、hs-CRP 水平;检测大动脉粥样硬化型脑卒中患者入院时与治疗14 d 时血清半乳糖凝集素-3、hs-CRP 水平和统计90 d 的采用改良RANKIN 量表(mRS)评分。结果治疗后,实验组血清半乳糖凝集素-3、hs-CRP 水平、mRS 评分均较对照组降低(P <0.05)。结论注射用丹参多酚酸可降低LAA 型脑卒中患者血清中半乳糖凝集素-3、hs-CRP 水平,促进神经功能恢复。 展开更多
关键词 卒中 丹参酚酸 半乳糖凝集素-3 超敏C 反应蛋白
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部